Redox biology of Leishmania and macrophage targeted nanoparticles for therapy

Development of mannose-anchored thiolated amphotericin B nanocarriers for treatment of visceral leishmaniasis

(2017) Gul Shahnaz et al.   Nanomedicine

Leishmania and the macrophage: a multifaceted interaction

(2015) Maria Podinovskaia et al.   Future Microbiology

Targeted chemotherapy of visceral leishmaniasis by lactoferrin-appended amphotericin B-loaded nanoreservoir: in vitro and in vivo studies.

(2015) Shalini Asthana et al.   Nanomedicine

Development of targeted 1,2-diacyl-sn-glycero-3-phospho-l-serine-coated gelatin nanoparticles loaded with amphotericin B for improvedin vitroandin vivoeffect in leishmaniasis

(2014) Renuka Khatik et al.   Expert Opinion on Drug Delivery

Drug resistance in leishmaniasis: current drug-delivery systems and future perspectives

(2013) Masoom Yasinzai et al.   Future Medicinal Chemistry

Leishmania donovaniPrevents Oxidative Burst-mediated Apoptosis of Host Macrophages through Selective Induction of Suppressors of Cytokine Signaling (SOCS) Proteins

(2013) Supriya Srivastav et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Development of nanocapsules bearing doxorubicin for macrophage targeting through the phosphatidylserine ligand: a system for intervention in visceral leishmaniasis

(2012) S. Kansal et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

News & Views in ... Nanomedicine

(2012)   Nanomedicine

Receptor-mediated phagocytosis of Leishmania: implications for intracellular survival

(2012) Norikiyo Ueno et al.   TRENDS IN PARASITOLOGY

Mechanism of Amphotericin B Resistance in Clinical Isolates of Leishmania donovani

(2011) Bidyut Purkait et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

A novel mechanism for an old drug: Amphotericin B in the treatment of visceral leishmaniasis

(2011) Amitabha Chattopadhyay et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Thiomers: Inhibition of cytochrome P450 activity

(2011) Javed Iqbal et al.   EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS

Leishmania–macrophage interactions: Insights into the redox biology

(2011) Tim Van Assche et al.   FREE RADICAL BIOLOGY AND MEDICINE

Polyamine metabolism in Leishmania: from arginine to trypanothione

(2010) Gianni Colotti et al.   AMINO ACIDS

In vitroevaluation of surface functionalized gelatin nanoparticles for macrophage targeting in the therapy of visceral leishmaniasis

(2010) Manoj Nahar et al.   JOURNAL OF DRUG TARGETING

The crystal structure of trypanothione reductase from the human pathogen Trypanosoma cruzi at 2.3 Å resolution

(2010) Yihong Zhang et al.   PROTEIN SCIENCE

Trypanothione efficiently intercepts nitric oxide as a harmless iron complex in trypanosomatid parasites

(2009) Alessio Bocedi et al.   FASEB JOURNAL

Determination of glutathione and glutathione disulfide in biological samples: An in-depth review

(2009) Péter Monostori et al.   JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES

The γ-glutamylcysteine synthetase gene of Leishmania is essential and involved in response to oxidants

(2009) Angana Mukherjee et al.   MOLECULAR MICROBIOLOGY

Leishmania GP63 Alters Host Signaling Through Cleavage-Activated Protein Tyrosine Phosphatases

(2009) M. A. Gomez et al.   Science Signaling

The nitric oxide–iron interplay in mammalian cells: Transport and storage of dinitrosyl iron complexes

(2008) Des R. Richardson et al.   BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS

Redox control in trypanosomatids, parasitic protozoa with trypanothione-based thiol metabolism

(2008) R. Luise Krauth-Siegel et al.   BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS

Drug delivery systems against leishmaniasis? Still an open question

(2008) Eder L Romero et al.   Expert Opinion on Drug Delivery

Leishmania major ascorbate peroxidase overexpression protects cells against reactive oxygen species-mediated cardiolipin oxidation

(2008) Subhankar Dolai et al.   FREE RADICAL BIOLOGY AND MEDICINE